Net Medical Xpress Solutions, Inc. (NMXS)
OTCMKTS · Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
At close: Feb 9, 2026

NMXS Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Operating Revenue
2.683.054.224.584.813.91
2.683.054.224.584.813.91
Revenue Growth (YoY)
-17.41%-27.88%-7.88%-4.74%23.20%21.77%
Cost of Revenue
1.992.273.063.773.652.98
Gross Profit
0.690.771.170.821.160.92
Selling, General & Admin
0.820.940.891.070.940.81
Research & Development
0.080.090.10.120.160.07
Other Operating Expenses
------0
Operating Expenses
0.91.031.011.281.120.91
Operating Income
-0.21-0.260.16-0.470.040.02
Interest Expense
-0.01-0.01-0.01-0.02-0.01-0.01
EBT Excluding Unusual Items
-0.22-0.260.15-0.480.030.01
Impairment of Goodwill
-0.08-0.08----
Pretax Income
-0.3-0.340.15-0.480.030.01
Net Income
-0.3-0.340.15-0.480.030.01
Net Income to Common
-0.3-0.340.15-0.480.030.01
Net Income Growth
----500.00%-
Shares Outstanding (Basic)
191919181817
Shares Outstanding (Diluted)
191920181817
Shares Change (YoY)
0.13%-5.03%12.03%-9.78%2.84%
EPS (Basic)
-0.02-0.020.01-0.030.000.00
EPS (Diluted)
-0.02-0.020.01-0.030.000.00
EPS Growth
----448.00%-
Free Cash Flow
-0.19-0.080.13-0.20.23-0.07
Free Cash Flow Per Share
-0.01-0.000.01-0.010.01-0.00
Gross Margin
25.76%25.32%27.64%17.85%24.13%23.64%
Operating Margin
-8.00%-8.37%3.79%-10.17%0.87%0.43%
Profit Margin
-11.33%-11.30%3.58%-10.52%0.62%0.13%
Free Cash Flow Margin
-7.07%-2.63%3.06%-4.36%4.86%-1.69%
EBITDA
-0.21-0.240.18-0.440.070.05
EBITDA Margin
-7.92%-7.98%4.36%-9.58%1.41%1.15%
D&A For EBITDA
00.010.020.030.030.03
EBIT
-0.21-0.260.16-0.470.040.02
EBIT Margin
-8.00%-8.37%3.79%-10.17%0.87%0.43%
Revenue as Reported
2.683.054.224.584.813.91
Source: S&P Global Market Intelligence. Standard template. Financial Sources.